Tag: breast cancer diagnostics market report

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Breast Cancer Diagnostics Global Market Report 2024 Market from 2024 to 2033?

The breast cancer diagnostics market is expected to grow significantly, from $4.42 billion in 2023 to $4.8 billion in 2024, with a CAGR of 8.7%. This growth is driven by awareness campaigns, advancements in mammography screening, genetic testing, and a multidisciplinary approach to care.

The breast cancer diagnostics market is expected to see steady growth, reaching $6.47 billion by 2028, with a CAGR of 7.7%. The growth is attributed to advancements in personalized medicine, liquid biopsy techniques, 3D mammography, AI, and telemedicine. Major trends include developments in imaging technologies and AI integration.

Claim Your Free Sample of the Global Breast Cancer Diagnostics Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

What Key Factors Are Fueling the Growth of the Breast Cancer Diagnostics Global Market Report 2024 Market?

The rising incidence of breast cancer is increasing the demand for diagnostic equipment, thereby driving the breast cancer diagnostics market. Breast cancer is the most common form of cancer, affecting 2.1 million women annually and causing the highest number of cancer-related deaths in women. Early detection is key to improving treatment outcomes, and according to the American Cancer Society, over 287,850 new invasive breast cancer cases and 51,400 cases of DCIS were expected in 2022, contributing to an estimated 43,250 breast cancer-related deaths. This growing incidence will propel the market for breast cancer diagnostics.

What Are the Major Segments of the Breast Cancer Diagnostics Global Market Report 2024 Market?

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

What New Trends Are Transforming the Breast Cancer Diagnostics Global Market Report 2024 Market?

Technological advancements are driving growth in the breast cancer diagnostics market, with innovations like 3D mammography, or breast tomosynthesis, that provide detailed, three-dimensional breast images. In September 2022, Niramai launched Thermalytix, an AI-based breast cancer screening tool using thermal imaging to aid in early diagnosis.

Order Now for Fast Delivery of Your Breast Cancer Diagnostics Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Which Regions Are Driving Growth in the Breast Cancer Diagnostics Global Market Report 2024 Market?

North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Breast Cancer Diagnostics Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the breast cancer diagnostics global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Breast Cancer Diagnostics Global Market Report 2024 Market Include

1. Breast Cancer Diagnostics Global Market Report 2024 Market Executive Summary

2. Breast Cancer Diagnostics Global Market Report 2024 Market Segments

3. Breast Cancer Diagnostics Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Breast Cancer Diagnostics Global Market Report 2024 Market Trends

5. Major Breast Cancer Diagnostics Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Breast Cancer Diagnostics Global Market Report 2024 Market

26. Top Breast Cancer Diagnostics Global Market Report 2024 Companies

27. Breast Cancer Diagnostics Global Market Report 2024 Market Opportunities And Strategies

28. Breast Cancer Diagnostics Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Diuretics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Antibody Drug Conjugates Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The breast cancer diagnostics market has witnessed robust growth, driven by various factors such as awareness campaigns, technological advancements, and a multidisciplinary approach. As we delve into the details, it’s evident that the market is poised for further expansion, reaching $4.8 billion in 2024 at a CAGR of 8.7% and projecting an even more impressive growth to $6.47 billion in 2028 at a CAGR of 7.7%.

Factors Fueling Historic Growth

• Awareness and Screening Campaigns: Public awareness initiatives have played a pivotal role in promoting early detection and screening.
• Mammography Screening: The prevalence of mammography screening has contributed significantly to the historic growth.
• Technological Advancements: Continuous advancements in diagnostic technologies have enhanced accuracy and efficiency.
• Genetic Testing: The integration of genetic testing has provided crucial insights into the genetic basis of breast cancer.
• Multidisciplinary Approach: A collaborative approach involving multiple disciplines has improved overall diagnostics and treatment strategies.

The Role of Government Funding
Government Initiatives and Funding: A Path to Improved Healthcare

• Financial Support: Governments worldwide allocate substantial funds to support breast cancer research, prevention, and treatment.
• Program Implementation: Various programs aim to raise awareness, promote early detection, and provide financial assistance to underserved communities.
• Australian Example: The Australian Government allocated $40.7 million in its 2022-23 budget, focusing on enhancing accessibility and timely referrals, with $9.7 million specifically earmarked for breast cancer screening.

Market Players Driving Innovation
Innovations in Breast Cancer Diagnostics Market

• Key Companies: Major players like Abbott Laboratories, Hologic Inc., and Thermo Fisher Scientific Inc. are driving innovation in breast cancer diagnostics.
• AI-based Diagnosis: Artificial intelligence is revolutionizing breast cancer diagnosis, offering high accuracy and efficiency.
• Digistain’s Breakthrough: In December 2022, Digistain, a UK-based biotech company, launched an AI breast cancer diagnostic tool with over 99% accuracy, reducing waiting times and cutting costs significantly.

Read More On The Breast Cancer Diagnostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Strategic Moves: Hologic’s Acquisition
Strategic Acquisition – Hologic Expands Breast Health Solutions With Somatex

• Acquisition Details: In January 2021, Hologic acquired Somatex Medical for $64 million, reinforcing its commitment to comprehensive breast health solutions.
• Somatex’s Contribution: Somatex, a German-based provider of breast cancer diagnostic services, adds value to Hologic’s offerings.

Market Segmentation Overview
Understanding the Breast Cancer Diagnostics Market

1. By Type:
   • Imaging
   • Biopsy
   • Genomic Tests
   • Blood Tests
   • Other Types
2. By Technology:
   • Fluorescent In Situ Hybridization (FISH)
   • Comparative Genomic Hybridization (CGH)
   • Immunohistochemical (IHC)
   • Other Technologies
3. By Cancer Type:
   • BRCA Breast Cancer
   • ER & PR Breast Cancer
   • HER 2 Breast Cancer
   • EGFR Mutation Test Breast Cancer
   • Other Cancer Types
4. By Diagnostic Type:
   • Ionizing Breast Imaging Technologies
   • Non-ionizing Imaging Technologies
5. By End Users:
   • Hospitals and Clinics
   • Cancer Research Centers
   • Diagnostic Laboratories
   • Ambulatory Surgical Centers

Regional Dominance: North America Leads the Way

• Largest Market: In 2023, North America emerged as the largest region in the breast cancer diagnostics market, underscoring the region’s commitment to advancements in healthcare.

Conclusion
The breast cancer diagnostics market is not just witnessing growth; it’s evolving through innovations, government support, and strategic acquisitions. As we move forward, the focus on personalized medicine, liquid biopsies, AI, and machine learning promises to reshape the landscape, providing hope for improved diagnostics and outcomes in the fight against breast cancer. With a strong foundation laid in the historic period, the forecasted growth reflects a promising trajectory, marking a significant step towards a future with enhanced breast cancer diagnostics and treatment solutions.

Request for A Sample Of The Global Breast Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=3284&type=smp